CAS 1831128-32-5

Lacnotuzumab

CAS : 1831128-32-5

Lacnotuzumab (MCS110) is a humanized monoclonal antibody targeting CSF-1, which can be used in research on retinal diseases.

Degré de pureté : >95%

Couleur et forme : Liquid

Masse moléculaire : 144.8 kDa

Ref: TM-T76868

Lacnotuzumab

CAS : 1831128-32-5

A humanized IgG1/κ monoclonal antibody targeting CSF-1.

Ref: 3D-CLA1473